Jeonbuk National University spin-off to accelerate drug development through AI transformation
Hops BioSciences, a startup spun off from Jeonbuk National University, has been selected for the Daonda Program, a global corporate collaboration initiative. The university said that through the program, the company will pursue an artificial intelligence (AI) transformation strategy aimed at integrating AI throughout the drug development process. The program is jointly operated by the Ministry of…
Hops BioSciences, a spin-off from Jeonbuk National University, has been chosen for the Daonda Program, a global corporate collaboration initiative. The program, operated by the Ministry of SMEs and Startups, the Korea Institute of Startup and Entrepreneurship Development, and Dassault Systèmes, aims to enhance the technological competitiveness of promising Korean startups.
Hops BioSciences plans to leverage AI technologies throughout the drug development process, with the goal of dramatically reducing development time and costs. CEO Lee Jeong-hwan expressed optimism about the integration of AI, stating that the company aims to become an AI transformation company.
Brief written by urgent.news from The Korea Times's own syndicated text. Machine-written — it may contain errors, so check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
